Review article · 2022 · Open access

Biofluid‐based biomarkers for Alzheimer's disease–related pathologies: An update and synthesis of the literature

Henrik Zetterberg

Alzheimer s & Dementia, 18(9), 1687–1693 · Published 25 February 2022 · DOI 10.1002/alz.12618

Open full textView at the publisherCite this paper

In brief

“Biofluid‐based biomarkers for Alzheimer's disease–related pathologies: An update and synthesis of the literature” is a 2022 review article by Henrik Zetterberg, published in Alzheimer s & Dementia. OpenAlex counts 61 citations as of 18 November 2026, which puts it in the top 2% of works published in 2022 by citations. It is open access: the full text is free to read at PubMed Central.

Citations
61
Most cited in
2024 (22)
Field-weighted impact
1.71
References
74
Authors
1

Abstract

The past few years have seen an explosion in sensitive and specific assays for cerebrospinal fluid (CSF) and blood biomarkers for Alzheimer's disease (AD) and related disorders, as well as some novel assays based on pathological seed-induced protein misfolding in patient samples. Here, I review this exciting field that promises to transform dementia diagnostics and disease monitoring. I discuss data on biomarkers for amyloid beta (Aβ) and tau pathology, neurodegeneration, and glial activation, mention the most promising biomarkers for α-synuclein and TDP-43 pathology, and highlight the need for further research into common co-pathologies. Finally, I consider practical aspects of blood-based biomarker-supported AD diagnostics and emphasize the importance of biomarker interpretation in a full clinical context.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Zetterberg, H. (2022). Biofluid‐based biomarkers for Alzheimer's disease–related pathologies: An update and synthesis of the literature. Alzheimer s & Dementia, 18(9), 1687–1693. https://doi.org/10.1002/alz.12618

MLA 9

Zetterberg, Henrik. “Biofluid‐based biomarkers for Alzheimer's disease–related pathologies: An update and synthesis of the literature.” Alzheimer s & Dementia, vol. 18, no. 9, 2022, pp. 1687–1693. https://doi.org/10.1002/alz.12618.

Chicago

Zetterberg, Henrik. 2022. “Biofluid‐based biomarkers for Alzheimer's disease–related pathologies: An update and synthesis of the literature.” Alzheimer s & Dementia 18 (9): 1687–1693. https://doi.org/10.1002/alz.12618.

Harvard

Zetterberg, H. (2022) ‘Biofluid‐based biomarkers for Alzheimer's disease–related pathologies: An update and synthesis of the literature’, Alzheimer s & Dementia, 18(9), pp. 1687–1693. doi:10.1002/alz.12618.

IEEE

H. Zetterberg, “Biofluid‐based biomarkers for Alzheimer's disease–related pathologies: An update and synthesis of the literature,” Alzheimer s & Dementia, vol. 18, no. 9, pp. 1687–1693, 2022, doi: 10.1002/alz.12618.

BibTeX

@article{zetterberg2022biofluid,
  title     = {{Biofluid‐based biomarkers for Alzheimer's disease–related pathologies: An update and synthesis of the literature}},
  author    = {Zetterberg, Henrik},
  journal   = {Alzheimer s \& Dementia},
  year      = {2022},
  volume    = {18},
  number    = {9},
  pages     = {1687--1693},
  doi       = {10.1002/alz.12618},
  url       = {https://doi.org/10.1002/alz.12618}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202266
20231414
20242222
20251111
202688

Its field-weighted citation impact is 1.71: it has been cited 1.71 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research

  • Alzheimer's disease
  • biomarkers

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Zetterberg, H. (2022). Biofluid‐based biomarkers for Alzheimer's disease–related pathologies: An update and synthesis of the literature. Alzheimer s & Dementia, 18(9), 1687–1693. https://doi.org/10.1002/alz.12618

How many times has this paper been cited?

61 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at PubMed Central: sign in and open the full text from this page.

Who wrote this paper?

Henrik Zetterberg.

What is the DOI of this paper?

10.1002/alz.12618, permanently at https://doi.org/10.1002/alz.12618. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.